Nuvation Bio Inc - NUVB Enterprise Value-to-Sales Ratio

Official company branding of nuvationbio.com (NUVB)

The implementation of "green chemistry" principles to reduce synthesis toxicity is driving interest in Nuvation Bio Inc. (NUVB). This EV/Revenue chart visualizes this demand, where 5718.34 shows the current value of the metric. The asset's price action remains independent of economic cycles, relying instead on the success of clinical trials. Nuvation Bio Inc. (NUVB) is currently scaling targeted therapies following the integration of acquired international clinical programs.

Nuvation Corp (NUVB): Company Value to Revenue from 11/23/2025 to 11/20/2026

Nuvation Pharma - analytical breakdowns and key metrics (NUVB)

Fundamental company valuation:NUVB, nuvationbio.com
Manufactured products of Nuvation Bio Inc

For Nuvation Bio Inc. (NUVB), investment attractiveness is based on the retention of rare oncology talent. The EV/Sales trajectory reflects the business value, adjusted for net debt and correlated with annual turnover. This metric allows for an assessment of the real market value of assets without distortions from financial liabilities. This chart reveals the company's resilience to volatility. Low values may signal a risk of liquidity shortages.

Competitor analysis